KO‘KRAK BEZI SARATONIDA SKRINING DASTURLARINING SAMARADORLIGI
Ключевые слова:
ko‘krak bezi saratoni, skrining dasturi, mammografiya, erta diagnostika, profilaktikaАннотация
Ko‘krak bezi saratoni dunyo miqyosida ayollar orasida eng ko‘p uchraydigan onkologik kasalliklardan biri hisoblanadi va o‘lim ko‘rsatkichining yuqoriligi bilan ajralib turadi. Kasallikni erta bosqichlarda aniqlash bemorlarning yashash davomiyligini oshirish hamda davolash samaradorligini ta’minlashda muhim ahamiyat kasb etadi. Mazkur tadqiqotda ko‘krak bezi saratonini aniqlashga qaratilgan skrining dasturlarining tibbiy, ijtimoiy va iqtisodiy samaradorligi tahlil qilinadi. Mammografiya, ultratovush tekshiruvi hamda klinik ko‘rik kabi skrining usullarining kasallikni erta diagnostika qilishdagi o‘rni ilmiy manbalar asosida yoritilgan.Skrining dasturlarining muntazam amalga oshirilishi kasallikning invaziv bosqichga o‘tishining oldini olish, o‘lim ko‘rsatkichini kamaytirish hamda sog‘liqni saqlash tizimiga tushadigan iqtisodiy yukni kamaytirishga xizmat qilishi aniqlangan. Tadqiqot natijalari skrining dasturlarini aholining xavf guruhlari orasida keng joriy etish, ayollarning tibbiy savodxonligini oshirish hamda profilaktik tekshiruvlarga jalb etish zarurligini ko‘rsatadi. Shuningdek, milliy skrining strategiyalarini takomillashtirish orqali ko‘krak bezi saratonidan kelib chiqadigan asoratlar va mortalitet darajasini sezilarli kamaytirish mumkinligi asoslab beriladi.
Библиографические ссылки
1. World Health Organization. Breast cancer: Early diagnosis and screening guidelines. Geneva: WHO Press, 2023.
2. Tabár L., Vitak B., Chen H.H.T. Swedish Two-County Trial: Impact of Mammographic Screening on Breast Cancer Mortality. Radiologic Clinics of North America, 2017, Vol. 55(3), pp. 459–472.
3. Duffy S.W., Vulkan D., Cuckle H. et al. Effect of Mammographic Screening from Age 40 Years on Breast Cancer Mortality. The Lancet Oncology, 2020, Vol. 21(9), pp. 1165–1172.
4. Nelson H.D., Fu R., Cantor A. Effectiveness of Breast Cancer Screening: Systematic Review and Meta-analysis. Annals of Internal Medicine, 2016, Vol. 164(4), pp. 244–255.
5. American Cancer Society. Breast Cancer Facts & Figures 2022–2024. Atlanta: ACS Publications, 2024.
6. Smith R.A., Andrews K., Brooks D. Cancer Screening in the United States: Review of Current Guidelines. CA: A Cancer Journal for Clinicians, 2023, Vol. 73(1), pp. 17–48.
7. O‘zbekiston Respublikasi Sog‘liqni saqlash vazirligi. Onkologik kasalliklarni erta aniqlash va skrining dasturlarini tashkil etish bo‘yicha milliy klinik tavsiyalar. Toshkent, 2022.
8. IARC (International Agency for Research on Cancer). Breast Cancer Screening Handbook. Lyon: IARC Press, 2019.
9. Marmot M.G., Altman D.G., Cameron D.A. The Benefits and Harms of Breast Cancer Screening. British Journal of Cancer, 2013, Vol. 108(11), pp. 2205–2240.
10. Berry D.A., Cronin K.A., Plevritis S.K. Effect of Screening and Adjuvant Therapy on Breast Cancer Mortality. New England Journal of Medicine, 2005, Vol. 353, pp. 1784–1792.
